pfizer_istock-458618835_no_limit_pictures-

no_limit_pictures / iStockphoto.com

29 May 2017Americas

Pfizer asks district court to exclude expert testimony in competition case

Pfizer has filed a motion to exclude a declaration and testimony supporting a class of direct purchasers that have accused it of anti-competitive conduct.

Already registered?

Login to your account

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More features

Fed Circ orders Teva to delist five patents from Orange Book

Sarepta wins $115M in patent dispute over muscular dystrophy drug

Novartis shields eye-drop patent at European Patent Office

CREATES Act unfairly tips the scales to generics

LSPN launches its first-ever US awards to celebrate life sciences leaders

Pharma giants seek closure on COVID-19 vaccine rows

How Inhibrx defended a $450m damages suit

Foley & Lardner adds litigation and transaction expert in New York